A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host. - Harding CM; Nasr MA; Scott NE; Goyette-Desjardins G; Nothaft H; Mayer AE; Chavez SM; Huynh JP; Kinsella RL; Szymanski CM; Stallings CL; Segura M; et al. (Nature communications, 2019)